ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

SCLP Scancell Holdings Plc

10.50
-0.625 (-5.62%)
02 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Scancell Holdings Plc LSE:SCLP London Ordinary Share GB00B63D3314 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.625 -5.62% 10.50 10.00 11.00 11.125 10.50 11.13 645,415 09:13:14
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 5.27M -11.94M -0.0129 -8.14 97.42M
Scancell Holdings Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SCLP. The last closing price for Scancell was 11.13p. Over the last year, Scancell shares have traded in a share price range of 7.65p to 18.125p.

Scancell currently has 927,819,977 shares in issue. The market capitalisation of Scancell is £97.42 million. Scancell has a price to earnings ratio (PE ratio) of -8.14.

Scancell Share Discussion Threads

Showing 16901 to 16921 of 67575 messages
Chat Pages: Latest  687  686  685  684  683  682  681  680  679  678  677  676  Older
DateSubjectAuthorDiscuss
14/8/2018
20:54
F the science and debate bring on 10p.
thelogman
14/8/2018
16:58
TF
Thanks for the sentiments.... Appreciated.
I have to say it's rather pleasant not having (almost) every post removed as has been the case for the last couple of days...
In fact, yes, even had one disagreemnt but so far it seems to have been amicably settled....
Long may it continue...
ATB

oldnotwise
14/8/2018
16:34
ONW. I much regret your leaving LSE BB but at least you have unencumbered FREE SPEECH here. And you need it M8. ATB
torquayfan
14/8/2018
13:43
GUFFAW -
inanaco
Premium * Member*
Price: 11.50
Today 13:09
" low share price is good for those that understand Scancell and keep topping up, LTH are not interested in 10% gains "
WHAT 10% GAINS are those HE speaks of ???
.
" i suppose LOUD works. ... but what you can do is get consensus on our science by others showing similar which is what wildforce, boom, and myself have done over the years, i will add in Puritas as well, because those posts still stand as good today as 4 years ago."
.
"4 years ago"....When HE was BUYING at 44.5p
Urging everyone to BUY,BUY,BUY... and HOLD
.
HE IS the LAST Spiv to 'critisise' anyone for Making/ Taking a PROFIT
*WE ALL* might opine, that = For HIM...LOUD didn't WORK

the real lozan
14/8/2018
13:22
Touch if blue but only due to a few buys and wide spread and PLUM reappears like PUFF the Magic Dragon.
If zi rubbedvthe lamp snd git 3 wishes Mu bee 1 would be fir him to SHUT UP.
He says HE said DONT CONfuse FACT with Rumour.
FACT we are 11p a share NOT £6.
Fact the Onky person who thinks they are above Chair of Nottingham Universy is baNANA s EGO but reality is he a Low life CONman and proven liar who would struggle with straining a sentence together as he has Appaling gramma as pointed out by Hot Wings

drdobson1
14/8/2018
13:21
What EXACTLY would anyone expect Mr Glencross, of Calculus { Major SCLP shareholder / interest}... to SAY ???
What he SAYS and What he thinks/plans... are in his interest to SAY
Does ANYONE EXPECT him to SAY anything other ???
In PUBLIC ???

the real lozan
14/8/2018
13:15
Chelsea

I can see why he is crying, threw his toys out of the pram and cancelled level two on lse. He has had many posts pulled over the last two days. For being rude, personal and posting live Data, which is now not allowed.

At least we don’t have to read his silly posts every two minutes on sp’s and buys and sells. Half of them, he got wrong anyway.

Thanks to all, who reported his posts. Gave him a taste of his own medicine.

agema
14/8/2018
13:11
Old

As scancells biggest shareholder, it was obvious they would want to steady the ship. For the time being. Until some good news hit and they can sell into any share price rise. Which I think they will do. As they have already expressed displeasure.

Fact, also still remains. Scancells biggest shareholder has nobody on the Board, in the boardroom.

agema
14/8/2018
13:11
It’s funny as a few weeks ago we got news that Scancell had sorted out TriGrid for SCIB1 Combo which is due to commence later this year. And this tweet basically just confirms exactly that. We already had the news anyway it’s just the normal aim drip of a share price causing doubt.
rhatton
14/8/2018
13:04
Just a thought....
I wonder whether Glencross will now let us into the reason why our NED resigned last week?
Maybe the CEO's chat will have given some details for that... Was it coneected with the release of Information (or retention of same) that might assist the SP?
I don't know, but again, not an unreasonable issue to think about.
Or on a more positive note, maybe it was a discussion about another Calculus connected appointee to the BOD as a replacement? Perhaps a pending announcement? Who knows?
So there's plenty to think about from that tweet.
ATB

oldnotwise
14/8/2018
12:59
Wigwammer
Let's hope so!
ATB

oldnotwise
14/8/2018
12:58
ONW - we both believe in free speech. Jolly good. Up we go :)
wigwammer
14/8/2018
12:51
Wigwammer
Let's just say that you see the tweet as positive (obviously it gives information that's what Investors want to hear).
That's fine.
But, if you look a little deeper there's some less positive issues which bear thinking about...
Using history, do you recall the Moditope announcement and the fact that the share price flew when it was made.
Since then the share price hasn't resumed the upward trajectory on a sustained basis.
This share price fall (Plus dilution) has ocurred against evermore positive Scientififc eveidence of extraordinary potential in scancell's Platforms.
This has surprised many (not all) but many investors. Some have learnt along the way that maybe a share doesn't follow a straight line graph plot when good or bad news arrives.
With this announcement it seems that there's a positive news, but it's still worth looking at the alternate view of what the announcement actually MEANS.... So that we're not surprised if the wider market takes that less positive stance.
That was all I was attempting to do.... promote a debate.
I've discussed this with you and made my point.
You've done the same.
We differ in what the announcement might mean.
Fair enough... we disagree.
Hope thats's not a problem for you, it certainly isn't for me.
At least I'm pretty confident that my view will remain on this BB for others to see and consider, as will yours.
Now that's what I call a public forum, don't you?
AIMO
ATB

oldnotwise
14/8/2018
12:34
The M F F F and certain 'others' seem to be 'delighted' with the latest 'bulletin'.
T'would 'appear', *WE ALL* CAN assume = Everything in the garden is Rosey...then
SO.... One might ask = WHY is the S P....11.25p ???
Or , as some might observe = STILL, A little FLAT in Landan ???

the real lozan
14/8/2018
12:21
ONW - you repeat the error. "I'm not sure there was ever any doubt that Calculus were still happy with SCLP.." There was both doubt and debate. As a result of today's tweet, the doubt should have receded. Regarding your other points - I suspect looking for negatives in the tweet rather than the more obvious positives tells me rather more about your position than about Scancell. Thanks for the shares :)
wigwammer
14/8/2018
11:58
Wigwammer
You're missing the point of this.
I said,
"I'm not sure there was ever any doubt that Calculus were still happy with SCLP, but some suggested that events could have suggested to the market that that might have been the case. Pure conjecture , but a valid point of view for discussion in the wider forum.
As to the Calculus tweet... Wonder why they felt the need? we know Glencross has shown his displeasure with the Commercial side of Scancell in the past (through the SP's record) but there's never (as far as I'm aware) ever been a question about the science.
Good to see the info has hit the street, but however you look at it it doesn't say much for Scancell's investor relations if a major shareholder has to put out the info many shareholders had apparently been looking for..."

Please don't take a part of a post out of context and attempt to capitalise on it!
Read the full post and the comments moved away from the overall tenet and moved deeper inrto specific issues without being dramatic or overly partisan.
I hope a reread will help you to understand the concept of "Nuance"
ATB

oldnotwise
14/8/2018
11:54
An interesting point ;- Those out of pocket investors who frequent the LSE BB, have already lost a lot of money by listening to the failure that is Ineptico, yet, they are clearly compounding their losses by a further £20/ month, or £240 / year by feeling the need to protect their " underwater " investment via the premier membership.
To take this even further, if certain individuals have been premier members for over 4 years, as im sure many of them have been, then thats another £1'000 loss to add to their already significant financial shortfall.
Just a thought.

tosh123
14/8/2018
11:52
"I'm not sure there was ever any doubt that Calculus were still happy with SCLP.." I think we must be reading different boards, ONW. The doubt should have receded as a consequence of this tweet, and I'm sure those doubters will concede this much in the interests of fair and rational debate ;)
wigwammer
14/8/2018
11:49
Wigwmmer
well done.... A great paste....
So what do you think about Calculus attempting to protect their investment by putting out info that the Scancell machine failed to do.?
Now, any links with the recent resignation from the BOD?
Looks a possiblity now?
Maybe...
let's watch the share price ...
AIMO
ATB

oldnotwise
14/8/2018
11:45
@GlencrossJohn "Good chat with Cliff Holloway, CEO of @scancellpharma, this morning. The SCIB1 combo trial previously announced by the company is on track with those sites already selected expected to initiate the study by year end as planned."
wigwammer
14/8/2018
11:44
Wigwammer (new recruit at LSE)
I'm not sure there was ever any doubt that Calculus were still happy with SCLP, but some suggested that events could have suggested to the market that that might have been the case. Pure conjecture , but a valid point of view for discussion in the wider forum.
As to the Calculus tweet... Wonder why they felt the need? we know Glencross has shown his displeasure with the Commercial side of Scancell in the past (through the SP's record) but there's never (as far as I'm aware) ever been a question about the science.
Good to see the info has hit the street, but however you look at it it doesn't say much for Scancell's investor relations if a major shareholder has to put out the info many shareholders had apparently been looking for...
AIMO
ATB

oldnotwise
Chat Pages: Latest  687  686  685  684  683  682  681  680  679  678  677  676  Older

Your Recent History

Delayed Upgrade Clock